AA
ENZN

Ancora Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Ancora Advisors’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$20K – 573
2016
Q2 		$20K Buy
+50,000
New +$24.8K ﹤0.01% 512

Other funds holding ENZN

PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Ancora Advisors's ENZN Position: Q3 2016 in Review

Ancora Advisors sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2016, closing a stake of 50,000 shares — an estimated $20K sold.

Ancora Advisors first reported a position in ENZN in Q2 2016 and held it in 1 quarter. The position peaked at $20K in Q2 2016. 4 funds tracked by Wall St. Rank hold ENZN as of Q3 2016.

  • Ancora Advisors reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2016 after selling out during the quarter.
  • Ancora Advisors sold 50,000 ENZON PHARMACEUTICALS INC shares in Q3 2016, an estimated $20K.
  • Ancora Advisors first reported a position in ENZON PHARMACEUTICALS INC in Q2 2016 and held it in 1 quarter.
  • Ancora Advisors's ENZON PHARMACEUTICALS INC position peaked at $20K in Q2 2016.
  • 4 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2016.

Based on Ancora Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.